vs
Side-by-side financial comparison of Aclaris Therapeutics, Inc. (ACRS) and ZW Data Action Technologies Inc. (CNET). Click either name above to swap in a different company.
ZW Data Action Technologies Inc. is the larger business by last-quarter revenue ($1.7M vs $1.3M, roughly 1.3× Aclaris Therapeutics, Inc.). On growth, ZW Data Action Technologies Inc. posted the faster year-over-year revenue change (-47.0% vs -85.9%). Over the past eight quarters, Aclaris Therapeutics, Inc.'s revenue compounded faster (-26.5% CAGR vs -56.8%).
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for immunological, inflammatory, and dermatological diseases. Its pipeline includes candidates for unmet needs like alopecia areata and vitiligo, serving global patient groups.
ZW Data Action Technologies Inc., trading under the symbol CNET, is a China-based technology enterprise focused on delivering integrated digital marketing solutions, big data analysis services, and intelligent operation tools for enterprise clients across sectors including e-commerce, consumer goods, and internet services. Its offerings help clients optimize user acquisition efficiency, boost operational performance, and advance digital transformation, primarily serving the Chinese domestic market and select Asia-Pacific clients.
ACRS vs CNET — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3M | $1.7M |
| Net Profit | — | $-108.0K |
| Gross Margin | 58.9% | 5.7% |
| Operating Margin | — | -8.9% |
| Net Margin | — | -6.3% |
| Revenue YoY | -85.9% | -47.0% |
| Net Profit YoY | 79.5% | 94.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3M | — | ||
| Q3 25 | $3.3M | $1.7M | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $1.5M | $1.7M | ||
| Q4 24 | $9.2M | $2.2M | ||
| Q3 24 | $4.3M | $3.2M | ||
| Q2 24 | $2.8M | $6.4M | ||
| Q1 24 | $2.4M | $3.5M |
| Q4 25 | — | — | ||
| Q3 25 | $-14.6M | $-108.0K | ||
| Q2 25 | $-15.4M | — | ||
| Q1 25 | $-15.1M | $-531.0K | ||
| Q4 24 | $-96.6M | $-781.0K | ||
| Q3 24 | $-7.6M | $-1.9M | ||
| Q2 24 | $-11.0M | $-216.0K | ||
| Q1 24 | $-16.9M | $-850.0K |
| Q4 25 | 58.9% | — | ||
| Q3 25 | 83.7% | 5.7% | ||
| Q2 25 | 71.0% | — | ||
| Q1 25 | 65.2% | 9.7% | ||
| Q4 24 | 92.3% | -0.4% | ||
| Q3 24 | 85.0% | 1.7% | ||
| Q2 24 | 77.4% | 5.1% | ||
| Q1 24 | 66.3% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | -519.8% | -8.9% | ||
| Q2 25 | -1035.9% | — | ||
| Q1 25 | -1242.9% | -35.0% | ||
| Q4 24 | -1082.3% | -24.1% | ||
| Q3 24 | -240.9% | -61.5% | ||
| Q2 24 | -464.7% | -4.7% | ||
| Q1 24 | -789.4% | -26.1% |
| Q4 25 | — | — | ||
| Q3 25 | -443.0% | -6.3% | ||
| Q2 25 | -868.3% | — | ||
| Q1 25 | -1036.8% | -32.1% | ||
| Q4 24 | -1048.3% | -34.7% | ||
| Q3 24 | -174.6% | -59.1% | ||
| Q2 24 | -397.2% | -3.4% | ||
| Q1 24 | -706.5% | -24.1% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.12 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $-0.12 | — | ||
| Q4 24 | $-1.21 | — | ||
| Q3 24 | $-0.11 | — | ||
| Q2 24 | $-0.15 | — | ||
| Q1 24 | $-0.24 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $20.0M | $1.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $103.1M | $3.3M |
| Total Assets | $160.5M | $9.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $20.0M | — | ||
| Q3 25 | $25.3M | $1.8M | ||
| Q2 25 | $25.4M | — | ||
| Q1 25 | $30.4M | $807.0K | ||
| Q4 24 | $24.6M | $812.0K | ||
| Q3 24 | $47.7M | $1.1M | ||
| Q2 24 | $22.8M | $510.0K | ||
| Q1 24 | $35.8M | $467.0K |
| Q4 25 | $103.1M | — | ||
| Q3 25 | $120.1M | $3.3M | ||
| Q2 25 | $131.7M | — | ||
| Q1 25 | $144.1M | $3.1M | ||
| Q4 24 | $155.6M | $3.7M | ||
| Q3 24 | $130.2M | $4.8M | ||
| Q2 24 | $133.8M | $5.2M | ||
| Q1 24 | $142.0M | $5.4M |
| Q4 25 | $160.5M | — | ||
| Q3 25 | $175.5M | $9.7M | ||
| Q2 25 | $189.1M | — | ||
| Q1 25 | $198.1M | $9.5M | ||
| Q4 24 | $220.3M | $9.7M | ||
| Q3 24 | $182.4M | $11.0M | ||
| Q2 24 | $161.1M | $10.8M | ||
| Q1 24 | $174.1M | $11.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-47.1M | $-482.0K |
| Free Cash FlowOCF − Capex | $-47.2M | — |
| FCF MarginFCF / Revenue | -3646.6% | — |
| Capex IntensityCapex / Revenue | 8.6% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-81.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-47.1M | — | ||
| Q3 25 | $-10.9M | $-482.0K | ||
| Q2 25 | $-10.0M | — | ||
| Q1 25 | $-13.1M | $-984.0K | ||
| Q4 24 | $-8.9M | $-830.0K | ||
| Q3 24 | $22.0M | $-198.0K | ||
| Q2 24 | $-12.3M | $-677.0K | ||
| Q1 24 | $-20.8M | $-353.0K |
| Q4 25 | $-47.2M | — | ||
| Q3 25 | $-11.0M | — | ||
| Q2 25 | $-10.0M | — | ||
| Q1 25 | $-13.1M | $-1.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-12.3M | — | ||
| Q1 24 | $-20.9M | — |
| Q4 25 | -3646.6% | — | ||
| Q3 25 | -332.1% | — | ||
| Q2 25 | -563.5% | — | ||
| Q1 25 | -900.3% | -61.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -446.0% | — | ||
| Q1 24 | -873.6% | — |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 0.7% | 0.0% | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 3.0% | 2.2% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 5.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACRS
Segment breakdown not available.
CNET
| Online Advertising Placement | $1.6M | 95% |
| Other | $83.0K | 5% |
